Intrinsic Value of S&P & Nasdaq Contact Us

Diversified Healthcare Trust DHC NASDAQ

NASDAQ Global Select • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
29/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
-31.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Diversified Healthcare Trust (DHC) has a negative trailing P/E of -6.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -16.79%.

Criteria proven by this page:

  • VALUE (63/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -16.79% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $5.00 (-31.6% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 29/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
VALUE
63/100
Price-to-Earnings & upside
Proven by this page
FUTURE
16/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
24/100
→ Income
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — DHC

Valuation Multiples
P/E (TTM)-6.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.02
P/S Ratio1.12
EV/EBITDA23.7
Per Share Data
EPS (TTM)$-1.19
Book Value / Share$6.93
Revenue / Share$6.40
FCF / Share$-0.07
Yields & Fair Value
Earnings Yield-16.79%
Dividend Yield0.56%
Analyst Target$5.00 (-31.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 31.8 2.86 1.40 4.25 8.25%
2017 30.9 9.27 1.39 4.24 8.13%
2018 9.7 0.10 0.88 2.49 13.32%
2019 -22.7 0.17 0.73 1.93 9.96%
2020 -7.0 -0.12 0.39 0.60 4.37%
2021 4.2 -0.02 0.28 0.53 1.30%
2022 -9.8 0.09 0.06 0.12 6.21%
2023 -3.0 0.00 0.38 0.63 1.07%
2024 -1.5 -0.06 0.28 0.37 1.75%
2025 -4.1 0.18 0.70 0.76 0.83%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.60 $1.06B $141.3M 13.4%
2017 $0.62 $1.07B $147.61M 13.7%
2018 $1.21 $1.12B $286.87M 25.7%
2019 $-0.35 $1.04B $-83.28M -8%
2020 $-0.56 $1.63B $-134.31M -8.2%
2021 $0.73 $1.38B $174.52M 12.6%
2022 $-0.09 $1.28B $-21.83M -1.7%
2023 $-1.23 $1.41B $-293.57M -20.8%
2024 $-1.55 $1.5B $-370.26M -24.8%
2025 $-1.19 $1.54B $-285.89M -18.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.54 $-0.54 – $-0.54 $1.57B $1.56B – $1.58B 1
2027 $-0.45 $-0.45 – $-0.44 $1.68B $1.67B – $1.69B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message